AHRI.IsisekeloSempilo.Clinical.Management.Datasets.v2.0
Isisekelo Sempilo:Clinical Management Datasets
Name | Country code |
---|---|
South Africa | ZA |
Isisekelo Sempilo: HIV prevention embedded in sexual health: A pilot trial to optimize peer (Thetha Nami) delivery of HIV prevention and care to adolescents and young adults in rural KwaZulu-Natal. Study aim: The overarching goal is to arrest the HIV epidemic and reduce its negative impact on young people in SA through rapidly developing and testing the efficacy and efficiency of tailored HIV care and prevention (including PrEP and UTT) that address demand, optimise access and support adherence in adolescents and young people. Our aim in this phase of the programme is to integrate exciting advances in participatory intervention development, process evaluation and adaptive trials to explore the hypothesis that, innovative and tailored HIV prevention interventions developed with and for young people will optimize models to deliver HIV prevention and care to men and women aged 16-29 living in a high HIV incidence area of rural South Africa. We will use the pilot to optimize the intervention and understand the relative importance of the different components in supporting the uptake of HIV care, prevention and contraception.
Specific objectives for the pilot trial:
Basic unit(s) of analysis or observation that the study describes: For PANGEA is each record a sequence from a specimen, or are there multiple records for a single specimen or study participant
V2.0.0
Topic | Vocabulary | URI |
---|---|---|
HIV prevention, sexual reproductive health, peer navigators, adaptive trial, homebased STI testing | Africa Health Research Institute | www.ahri.org |
Demographic surveillance area of the Africa Health Research Institute; KwaZulu-Natal, uMkhanyakude district
We will conduct a 2x2 factorial design intervention pilot trial including 1500 men and women aged 16-29-years old and living in the AHRI surveillance area. The study duration will be 18 months. For our primary outcomes of interest, we will assess uptake of comprehensive HIV prevention services, including Pre-Exposure Prophylaxis (PrEP) and Universal Test and Treat (UTT) and the reduction of the proportion of individuals at a population level with infectious HIV (population viral load).
Over a period of 12 months after randomisation we will collect routine data on uptake of Thetha Nami and Clinical Services as well as adverse events. At 12 months we will approach all those who consented at baseline by phone, in their homes or wherever they prefer to be seen. Following Informed Consent we will conduct a brief redcap survey to collect information on uptake and experience of HIV prevention and care services, uptake of contraception and incidence of pregnancy, mental health (using PHQ9), and quality of life. We will also offer point of care HIV testing and linkage to care, collect dry blood spot for HIV ELISA and HIV viral load, and offer STI testing and treatment to all. In addition, we will conduct a mixed-method process evaluation to collect data on uptake and retention and fidelity of each component of the intervention; assess service users and providers and the community experience, i.e. which facets of the package are valued; and any social harms. Finally, a costing analysis will be undertaken to establish the cost of delivering the intervention through the different models of care.
Name | Affiliation |
---|---|
Dr Maryam, Shahmanesh | Africa Health Research Institute |
Name |
---|
Africa Health Research Institute |
Name | Role |
---|---|
3ie | Funder |
Nationational Institute of Health | Funder |
Name | Affiliation | Role |
---|---|---|
Jaco Dreyer | Africa Health Research Institute | Data management, cleaning and analysis |
Research assistants will approach n=3000 16-29-year old males and females selected from the demographic surveillance area at their homesteads. We expect that 2000 will still be eligible, i.e. aged 16-29 and still living in the surveillance area. Research assistants will provide information about the study to all eligible participants and consent them to the random offer of HIV or sexual health interventions and follow-up with a survey and HIV testing at 12 months. We anticipate that n=1500 [75% (73-77%)] will consent to participate.
Start | End |
---|---|
2020-03-05 | 2022-07-04 |
The representative of the Receiving Organization agrees to comply with the following conditions:
DDI.AHRI.IsisekeloSempilo.Clinical.Management.Datasets.v2.0
Name |
---|
Africa Health Research Institute |